my personal edition > colorectal cancer > news


  E-Mail this item to a colleague

TopAbstracts in Colorectal Cancer 10/28/2009

TopAbstracts™ in Colorectal Cancer are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide™ newsletter or visited a website Powered by Doctor's Guide™ in the past 14 days. Over 2000 peer-reviewed journals are covered by TopAbstracts.

TopAbstracts - Past 14 days

• A Phase II Trial of Neoadjuvant Capecitabine Combined With Hyperfractionated Accelerated Radiation Therapy in Locally Advanced Rectal Cancer - (Am J Clin Oncol)
• The impact of new treatment options for advanced colorectal cancer on routine care: results of a retrospective analysis of 206 consecutive patients treated in a community-based oncology group practice in Germany - (Eur J Cancer Care)
• A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining - (Invest New Drugs)
• Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin - (Ann Oncol)
• Toxicity and Efficacy of 5-Fluorouracil and Capecitabine in a Patient With TYMS Gene Polymorphism: A Challenge or a Dilemma? - (Clin Colorectal Cancer)

E-Mail this item to a colleague

To print, use this version